Search by Drug Name or NDC
NDC 00409-6629-02 QUELICIN 20 mg/mL Details
QUELICIN 20 mg/mL
QUELICIN is a INTRAMUSCULAR; INTRAVENOUS INJECTION, SOLUTION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Hospira, Inc.. The primary component is SUCCINYLCHOLINE CHLORIDE.
Product Information
NDC | 00409-6629 |
---|---|
Product ID | 0409-6629_85396a53-f320-4200-a3fe-acbabcee1b6d |
Associated GPIs | 74100010102005 |
GCN Sequence Number | 004676 |
GCN Sequence Number Description | succinylcholine chloride VIAL 20 MG/ML INJECTION |
HIC3 | S7A |
HIC3 Description | NEUROMUSCULAR BLOCKING AGENTS |
GCN | 17992 |
HICL Sequence Number | 001948 |
HICL Sequence Number Description | SUCCINYLCHOLINE CHLORIDE |
Brand/Generic | Brand |
Proprietary Name | QUELICIN |
Proprietary Name Suffix | n/a |
Non-Proprietary Name | Succinylcholine Chloride |
Product Type | HUMAN PRESCRIPTION DRUG |
Dosage Form | INJECTION, SOLUTION |
Route | INTRAMUSCULAR; INTRAVENOUS |
Active Ingredient Strength | 20 |
Active Ingredient Units | mg/mL |
Substance Name | SUCCINYLCHOLINE CHLORIDE |
Labeler Name | Hospira, Inc. |
Pharmaceutical Class | Depolarizing Neuromuscular Blocker [EPC], Neuromuscular Depolarizing Blockade [PE] |
DEA Schedule | n/a |
Marketing Category | NDA |
Application Number | NDA008845 |
Listing Certified Through | 2024-12-31 |
Package
NDC 00409-6629-02 (00409662902)
NDC Package Code | 0409-6629-02 |
---|---|
Billing NDC | 00409662902 |
Package | 25 VIAL, MULTI-DOSE in 1 TRAY (0409-6629-02) / 10 mL in 1 VIAL, MULTI-DOSE (0409-6629-12) |
Marketing Start Date | 2005-04-30 |
NDC Exclude Flag | N |
Pricing Information | N/A |